Proteocyte Diagnostics Inc. — Form D
Proteocyte Diagnostics Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-18. The offering totals $37K, of which $37K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-18
- Form: D
- Accession: 0001062993-23-022719
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $37K
- Amount sold: $37K
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2023-12-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-499990
Issuer
- Name: Proteocyte Diagnostics Inc.
- CIK: 0001987946
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Address: MARS CENTRE, SOUTH TOWER, TORONTO, A6, M5G 1L7
- Phone: (647) 255-1370
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Steven Arless | Director | Toronto, A6 |
| John Jordan | Director | Denver, CO |
| Anthony Morlandt | Director | Toronto, A6 |
| Barrie Renick | Director | Toronto, A6 |
| Carlo Sistilli | Director | Markham, A6 |
| Mark Hammer | Executive Officer | Toronto, A6 |
| John Jordan | Executive Officer | Denver, CO |
Other filings by this issuer (1)
More